GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $245,000 | 0.0% | 5,625 | 0.0% | 0.06% | +57.1% |
| Q1 2022 | $245,000 | -1.2% | 5,625 | 0.0% | 0.04% | +6.1% |
| Q4 2021 | $248,000 | +15.3% | 5,625 | 0.0% | 0.03% | +6.5% |
| Q3 2021 | $215,000 | -4.0% | 5,625 | 0.0% | 0.03% | +3.3% |
| Q2 2021 | $224,000 | +11.4% | 5,625 | 0.0% | 0.03% | +3.4% |
| Q1 2021 | $201,000 | -5.2% | 5,625 | -2.2% | 0.03% | 0.0% |
| Q4 2020 | $212,000 | -2.3% | 5,753 | 0.0% | 0.03% | -23.7% |
| Q3 2020 | $217,000 | -10.0% | 5,753 | -2.5% | 0.04% | -7.3% |
| Q2 2020 | $241,000 | +10.6% | 5,903 | +2.6% | 0.04% | -29.3% |
| Q1 2020 | $218,000 | -19.3% | 5,753 | 0.0% | 0.06% | +52.6% |
| Q4 2019 | $270,000 | +9.8% | 5,753 | 0.0% | 0.04% | -5.0% |
| Q3 2019 | $246,000 | +7.0% | 5,753 | 0.0% | 0.04% | -4.8% |
| Q2 2019 | $230,000 | -4.2% | 5,753 | 0.0% | 0.04% | -10.6% |
| Q1 2019 | $240,000 | +11.6% | 5,753 | +2.3% | 0.05% | -11.3% |
| Q4 2018 | $215,000 | -4.9% | 5,625 | 0.0% | 0.05% | +47.2% |
| Q3 2018 | $226,000 | -0.4% | 5,625 | 0.0% | 0.04% | -14.3% |
| Q2 2018 | $227,000 | +3.2% | 5,625 | 0.0% | 0.04% | -4.5% |
| Q1 2018 | $220,000 | -6.4% | 5,625 | -3.0% | 0.04% | +10.0% |
| Q3 2017 | $235,000 | -3.3% | 5,797 | +3.1% | 0.04% | -4.8% |
| Q2 2017 | $243,000 | +2.5% | 5,625 | 0.0% | 0.04% | -10.6% |
| Q1 2017 | $237,000 | +9.2% | 5,625 | 0.0% | 0.05% | +27.0% |
| Q4 2016 | $217,000 | -10.7% | 5,625 | 0.0% | 0.04% | -24.5% |
| Q3 2016 | $243,000 | -0.4% | 5,625 | 0.0% | 0.05% | -5.8% |
| Q2 2016 | $244,000 | +7.0% | 5,625 | 0.0% | 0.05% | -11.9% |
| Q1 2016 | $228,000 | +0.4% | 5,625 | 0.0% | 0.06% | +9.3% |
| Q4 2015 | $227,000 | +5.1% | 5,625 | 0.0% | 0.05% | +3.8% |
| Q3 2015 | $216,000 | -7.7% | 5,625 | 0.0% | 0.05% | +10.6% |
| Q2 2015 | $234,000 | -10.0% | 5,625 | 0.0% | 0.05% | -9.6% |
| Q1 2015 | $260,000 | +8.3% | 5,625 | 0.0% | 0.05% | +23.8% |
| Q4 2014 | $240,000 | -7.3% | 5,625 | 0.0% | 0.04% | -10.6% |
| Q3 2014 | $259,000 | -14.0% | 5,625 | 0.0% | 0.05% | -7.8% |
| Q2 2014 | $301,000 | 0.0% | 5,625 | 0.0% | 0.05% | -5.6% |
| Q1 2014 | $301,000 | +0.3% | 5,625 | 0.0% | 0.05% | -3.6% |
| Q4 2013 | $300,000 | +6.4% | 5,625 | 0.0% | 0.06% | -1.8% |
| Q3 2013 | $282,000 | +0.4% | 5,625 | 0.0% | 0.06% | -10.9% |
| Q2 2013 | $281,000 | – | 5,625 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |